Skip to main content

Table 2 Detailed statistics of expression of VDR, CYP27B and SNHG6, SNHG16, Linc00511 and Linc00346 lncRNAs in COVID-19 patients and controls (RME: Ratio of mean expression)

From: Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients

  SNHG6 SNHG16 VDR Linc00511 Linc00346 CYP27B
Number of Samples SE RME P Value 95% CI SE RME P Value 95% CI SE RME P Value 95% CI SE RME P Value 95% CI SE RME P Value 95% CI SE RME P Value 95% CI
Cases/ controls
Total 91/91 0.54 0.22 0.00 −3.29 −1.14 0.56 0.20 0.00 −3.40 − 1.20 0.61 0.42 0.04 −2.44 −0.05 0.64 1.55 0.33 −0.64 1.90 0.62 1.34 0.50 −0.80 1.64 0.61 0.71 0.43 −1.69 0.72
F 38/39 0.78 0.32 0.04 −3.21 −0.09 0.79 0.32 0.04 −3.22 −0.05 0.89 0.78 0.68 −2.14 1.41 0.86 1.01 0.99 −1.71 1.74 0.98 1.98 0.32 −0.96 2.93 0.79 1.39 0.54 −1.09 2.04
M 53/52 0.75 0.16 0.00 −4.11 −1.14 0.78 0.14 0.00 −4.33 −1.25 0.82 0.27 0.02 −3.51 −0.25 0.92 2.11 0.25 −0.75 2.90 0.81 1.01 0.99 −1.59 1.61 0.88 0.43 0.17 −2.96 0.53
ICU/ Non-ICU
Total 37/54 0.75 1.74 0.29 −0.69 2.30 0.75 1.49 0.44 −0.91 2.06 0.84 0.90 0.85 −1.82 1.51 0.87 0.60 0.40 −2.47 0.99 0.84 0.73 0.59 −2.12 1.21 0.85 0.79 0.68 −2.03 1.34
F 13/25 0.97 2.18 0.26 −0.85 3.10 1.09 1.11 0.90 −2.12 2.41 1.29 0.90 0.91 −2.78 2.48 1.01 0.62 0.51 −2.74 1.38 1.46 0.59 0.61 −3.77 2.25 1.03 0.92 0.91 −2.22 1.99
M 24/29 1.10 1.64 0.52 −1.49 2.92 1.04 1.93 0.37 −1.14 3.04 1.12 1.05 0.95 −2.18 2.33 1.27 0.52 0.46 −3.50 1.61 1.03 0.90 0.88 −2.23 1.92 1.23 0.71 0.69 −2.98 1.98